Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
PR Newswire•07/10/2026•06:02 ET
0
Key Highlights
- ➤Joseph M. Fitzgerald becomes Boston Scientific COO effective Jan. 1, 2027
- ➤Boston Scientific establishes three reportable segments effective Jan. 1
- ➤Penumbra business will join Interventional Therapies after anticipated acquisition close
- ➤New operating structure targets faster decisions and strategic investment allocation
Expert Statements
Mike Mahoney, Chairman and Chief Executive Officer of Boston Scientific
“Joe's deep knowledge of our business and markets, strategic leadership and strong track record of execution make him well suited for this role.”
Mike Mahoney, Chairman and Chief Executive Officer of Boston Scientific
“These changes reflect the scale and breadth of our business today and the opportunities ahead. The new operating model will create greater capacity to focus on our long-term growth priorities while enabling our businesses to move faster and remain close to our customers and their patients.”
Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer PR Newswire
New operating structure designed to increase efficiency and support continued growth
Get started
Create a free account to read the full story.